{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T20:33:10Z","timestamp":1782592390751,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871819"],"award-info":[{"award-number":["81871819"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472135"],"award-info":[{"award-number":["81472135"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81000785"],"award-info":[{"award-number":["81000785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Enhanced osteoclastogenesis is one of the major causes of age-related bone loss. Aging is accompanied by accumulation of advanced oxidation protein products (AOPPs). However, whether AOPPs accumulation contributing to the osteoclastogenesis with aging remains unclear. Here, we showed that AOPPs accumulation was associated with the enhanced osteoclastogenesis and deterioration of bone microstructure in aged mice. In vitro, AOPPs directly induced osteoclastogenesis by interaction with receptor activator of nuclear factor \u03ba B (RANK) and the receptor for advanced glycation end products (RAGE) in the primary bone marrow monocytes. Bindings of AOPPs to RANK and RAGE were able to activate nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, trigger generation of reactive oxygen species, then induce phosphorylation of mitogen-activated protein kinases and c-fos, upregulation of the nuclear factor of activated T cell c1, eventually induce bone marrow monocytes to differentiate into mature osteoclasts. Chronic exposure to AOPPs enhanced osteoclastogenesis and bone loss in mice, which could be alleviated by NADPH oxidase inhibitor apocynin. Local injection of AOPPs into subperiosteal area induced bone resorption at the site of administration, which was similar to the effect of RANK ligand. Together, these results suggested that AOPPs could serve as a novel regulator of osteoclastogenesis and AOPPs accumulation might play an important role in the development of age-related bone loss.<\/jats:p>","DOI":"10.1038\/s41419-021-04441-w","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T18:02:45Z","timestamp":1639504965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Age-related accumulation of advanced oxidation protein products promotes osteoclastogenesis through disruption of redox homeostasis"],"prefix":"10.1038","volume":"12","author":[{"given":"Jingshen","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dizheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1480-028X","authenticated-orcid":false,"given":"Zhaoming","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,14]]},"reference":[{"key":"4441_CR1","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1359\/JBMR.050503","volume":"20","author":"JJ Cao","year":"2005","unstructured":"Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, et al. Aging increases stromal\/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. J Bone Miner Res. 2005;20:1659\u201368.","journal-title":"J Bone Miner Res"},{"key":"4441_CR2","doi-asserted-by":"crossref","unstructured":"Piemontese M, Almeida M, Robling AG, Kim HN, Xiong J, Thostenson JD, et al. Old age causes de novo intracortical bone remodeling and porosity in mice. JCI Insight. 2, e93771 (2017).","DOI":"10.1172\/jci.insight.93771"},{"key":"4441_CR3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/jbmr.3014","volume":"32","author":"S Ucer","year":"2017","unstructured":"Ucer S, Iyer S, Kim HN, Han L, Rutlen C, Allison K, et al. The effects of aging and sex steroid deficiency on the murine skeleton are independent and mechanistically distinct. J Bone Miner Res. 2017;32:560\u201374.","journal-title":"J Bone Miner Res"},{"key":"4441_CR4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/8756-3282(94)90893-1","volume":"15","author":"SL Perkins","year":"1994","unstructured":"Perkins SL, Gibbons R, Kling S, Kahn AJ. Age-related bone loss in mice is associated with an increased osteoclast progenitor pool. Bone 1994;15:65\u201372.","journal-title":"Bone"},{"key":"4441_CR5","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3389\/fimmu.2019.01483","volume":"10","author":"U Steffen","year":"2019","unstructured":"Steffen U, Schett G, Bozec A. How autoantibodies regulate osteoclast induced bone loss in rheumatoid arthritis. Front Immunol. 2019;10:1483.","journal-title":"Front Immunol"},{"key":"4441_CR6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/acel.12586","volume":"16","author":"HM Davis","year":"2017","unstructured":"Davis HM, Pacheco-Costa R, Atkinson EG, Brun LR, Gortazar AR, Harris J, et al. Disruption of the Cx43\/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging. Aging Cell. 2017;16:551\u201363.","journal-title":"Aging Cell"},{"key":"4441_CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337\u201342.","journal-title":"Nature"},{"key":"4441_CR8","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1074\/jbc.275.7.4858","volume":"275","author":"Y Azuma","year":"2000","unstructured":"Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem. 2000;275:4858\u201364.","journal-title":"J Biol Chem"},{"key":"4441_CR9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/path.1190","volume":"198","author":"O Kudo","year":"2002","unstructured":"Kudo O, Fujikawa Y, Itonaga I, Sabokbar A, Torisu T, Athanasou NA. Proinflammatory cytokine (TNFalpha\/IL-1alpha) induction of human osteoclast formation. J Pathol. 2002;198:220\u20137.","journal-title":"J Pathol"},{"key":"4441_CR10","doi-asserted-by":"crossref","unstructured":"Xiao Y, Cao Y, Song C, Ren X, Yan L, Hao D, et al. Cellular study of the LPS-induced osteoclastic multinucleated cell formation from RAW264.7 cells. J Cell Physiol. 2019;235:421\u201328.","DOI":"10.1002\/jcp.28982"},{"key":"4441_CR11","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3389\/fimmu.2017.01376","volume":"8","author":"JH Kim","year":"2017","unstructured":"Kim JH, Sim JH, Lee S, Seol MA, Ye SK, Shin HM, et al. Interleukin-7 induces osteoclast formation via STAT5, independent of receptor activator of NF-kappaB ligand. Front Immunol. 2017;8:1376.","journal-title":"Front Immunol"},{"key":"4441_CR12","volume":"10","author":"M Liang","year":"2019","unstructured":"Liang M, Ma Q, Ding N, Luo F, Bai Y, Kang F, et al. IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis. Cell Death Dis. 2019;10:353.","journal-title":"Cell Death Dis"},{"key":"4441_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(02)00915-8","volume":"32","author":"O Kudo","year":"2003","unstructured":"Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y, Athanasou NA. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 2003;32:1\u20137.","journal-title":"Bone"},{"key":"4441_CR14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/art.21821","volume":"54","author":"JR Edwards","year":"2006","unstructured":"Edwards JR, Sun SG, Locklin R, Shipman CM, Adamopoulos IE, Athanasou NA, et al. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis. Arthritis Rheum. 2006;54:1451\u201362.","journal-title":"Arthritis Rheum"},{"key":"4441_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2003.08.008","volume":"34","author":"I Itonaga","year":"2004","unstructured":"Itonaga I, Sabokbar A, Sun SG, Kudo O, Danks L, Ferguson D, et al. Transforming growth factor-beta induces osteoclast formation in the absence of RANKL. Bone 2004;34:57\u201364.","journal-title":"Bone"},{"key":"4441_CR16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/10731190500289784","volume":"33","author":"J Jiang","year":"2005","unstructured":"Jiang J, Lv HS, Lin JH, Jiang DF, Chen ZK. LTB4 can directly stimulate human osteoclast formation from PBMC independent of RANKL. Artif Cells Blood Substit Immobil Biotechnol. 2005;33:391\u2013403.","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"key":"4441_CR17","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1002\/art.24877","volume":"60","author":"L Rifas","year":"2009","unstructured":"Rifas L, Weitzmann MN. A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner. Arthritis Rheum. 2009;60:3324\u201335.","journal-title":"Arthritis Rheum"},{"key":"4441_CR18","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bone.2010.12.023","volume":"48","author":"F Hemingway","year":"2011","unstructured":"Hemingway F, Taylor R, Knowles HJ, Athanasou NA. RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II. Bone 2011;48:938\u201344.","journal-title":"Bone"},{"key":"4441_CR19","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.2174\/0929867323666160902154748","volume":"23","author":"M Cristani","year":"2016","unstructured":"Cristani M, Speciale A, Saija A, Gangemi S, Minciullo PL, Cimino F. Circulating advanced oxidation protein products as oxidative stress biomarkers and progression mediators in pathological conditions related to inflammation and immune dysregulation. Curr Med Chem. 2016;23:3862\u201382.","journal-title":"Curr Med Chem"},{"key":"4441_CR20","first-page":"4393460","volume":"2019","author":"M Maciejczyk","year":"2019","unstructured":"Maciejczyk M, Zalewska A, Ladny JR. Salivary antioxidant barrier, redox status, and oxidative damage to proteins and lipids in healthy children, adults, and the elderly. Oxid Med Cell Longev. 2019;2019:4393460.","journal-title":"Oxid Med Cell Longev"},{"key":"4441_CR21","doi-asserted-by":"crossref","first-page":"e12764","DOI":"10.1111\/acel.12764","volume":"17","author":"SY Zhu","year":"2018","unstructured":"Zhu SY, Zhuang JS, Wu Q, Liu ZY, Liao CR, Luo SG, et al. Advanced oxidation protein products induce pre-osteoblast apoptosis through a nicotinamide adenine dinucleotide phosphate oxidase-dependent, mitogen-activated protein kinases-mediated intrinsic apoptosis pathway. Aging Cell. 2018;17:e12764.","journal-title":"Aging Cell"},{"key":"4441_CR22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.redox.2017.09.011","volume":"14","author":"S Sun","year":"2018","unstructured":"Sun S, Xie F, Xu X, Cai Q, Zhang Q, Cui Z, et al. Advanced oxidation protein products induce S-phase arrest of hepatocytes via the ROS-dependent, beta-catenin-CDK2-mediated pathway. Redox Biol. 2018;14:338\u201353.","journal-title":"Redox Biol"},{"key":"4441_CR23","doi-asserted-by":"crossref","unstructured":"Garibaldi S, Barisione C, Marengo B, Ameri P, Brunelli C, Balbi M, et al. Advanced oxidation protein products-modified albumin induces differentiation of RAW264.7 macrophages into dendritic-like cells which is modulated by cell surface thiols. Toxins. 2017;9:27.","DOI":"10.3390\/toxins9010027"},{"key":"4441_CR24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10495-015-1191-4","volume":"21","author":"Q Wu","year":"2016","unstructured":"Wu Q, Zhong ZM, Zhu SY, Liao CR, Pan Y, Zeng JH, et al. Advanced oxidation protein products induce chondrocyte apoptosis via receptor for advanced glycation end products-mediated, redox-dependent intrinsic apoptosis pathway. Apoptosis 2016;21:36\u201350.","journal-title":"Apoptosis"},{"key":"4441_CR25","first-page":"3908","volume":"15","author":"J Zhang","year":"2018","unstructured":"Zhang J, Xiang X, Shu S, Zhang C, Liang Y, Jiang T, et al. Advanced oxidation protein products inhibit the autophagy of renal tubular epithelial cells. Exp Ther Med. 2018;15:3908\u201316.","journal-title":"Exp Ther Med"},{"key":"4441_CR26","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/cbin.10792","volume":"41","author":"S Sun","year":"2017","unstructured":"Sun S, Xie F, Zhang Q, Cui Z, Cheng X, Zhong F, et al. Advanced oxidation protein products induce hepatocyte epithelial-mesenchymal transition via a ROS-dependent, TGF-beta\/Smad signaling pathway. Cell Biol Int. 2017;41:842\u201353.","journal-title":"Cell Biol Int"},{"key":"4441_CR27","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.jss.2011.02.033","volume":"169","author":"YB Zhang","year":"2011","unstructured":"Zhang YB, Zhong ZM, Hou G, Jiang H, Chen JT. Involvement of oxidative stress in age-related bone loss. J Surg Res. 2011;169:e37\u201342.","journal-title":"J Surg Res"},{"key":"4441_CR28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.exger.2013.11.014","volume":"50","author":"JH Zeng","year":"2014","unstructured":"Zeng JH, Zhong ZM, Li XD, Wu Q, Zheng S, Zhou J, et al. Advanced oxidation protein products accelerate bone deterioration in aged rats. Exp Gerontol. 2014;50:64\u201371.","journal-title":"Exp Gerontol"},{"key":"4441_CR29","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ki.1996.186","volume":"49","author":"V Witko-Sarsat","year":"1996","unstructured":"Witko-Sarsat V, Friedlander M, Capeill\u00e8re-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304\u201313.","journal-title":"Kidney Int"},{"key":"4441_CR30","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1172\/JCI11468","volume":"106","author":"BL Riggs","year":"2000","unstructured":"Riggs BL. The mechanisms of estrogen regulation of bone resorption. J Clin Invest. 2000;106:1203\u20134.","journal-title":"J Clin Invest"},{"key":"4441_CR31","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/art.38001","volume":"65","author":"G Layh-Schmitt","year":"2013","unstructured":"Layh-Schmitt G, Yang EY, Kwon G, Colbert RA. HLA-B27 alters the response to tumor necrosis factor alpha and promotes osteoclastogenesis in bone marrow monocytes from HLA-B27-transgenic rats. Arthritis Rheum. 2013;65:2123\u201331.","journal-title":"Arthritis Rheum"},{"key":"4441_CR32","volume":"8","author":"HS Kim","year":"2017","unstructured":"Kim HS, Nam ST, Mun SH, Lee SK, Kim HW, Park YH, et al. DJ-1 controls bone homeostasis through the regulation of osteoclast differentiation. Nat Commun. 2017;8:1519.","journal-title":"Nat Commun"},{"key":"4441_CR33","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3109\/10715762.2011.564167","volume":"45","author":"B Liu","year":"2011","unstructured":"Liu B, Hou X, Zhou Q, Tian J, Zhu P, Xu J, et al. Detection of advanced oxidation protein products in patients with chronic kidney disease by a novel monoclonal antibody. Free Radic Res. 2011;45:662\u201371.","journal-title":"Free Radic Res"},{"key":"4441_CR34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.7939685","volume":"266","author":"AE Grigoriadis","year":"1994","unstructured":"Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994;266:443\u20138.","journal-title":"Science"},{"key":"4441_CR35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.11005\/jbm.2014.21.4.233","volume":"21","author":"JH Kim","year":"2014","unstructured":"Kim JH, Kim N. Regulation of NFATc1 in osteoclast differentiation. J Bone Metab. 2014;21:233\u201341.","journal-title":"J Bone Metab"},{"key":"4441_CR36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/08860220902875182","volume":"31","author":"H You","year":"2009","unstructured":"You H, Yang H, Zhu Q, Li M, Xue J, Gu Y, et al. Advanced oxidation protein products induce vascular calcification by promoting osteoblastic trans-differentiation of smooth muscle cells via oxidative stress and ERK pathway. Ren Fail. 2009;31:313\u20139.","journal-title":"Ren Fail"},{"key":"4441_CR37","doi-asserted-by":"crossref","unstructured":"Chen Q, Wang Q, Zhu J, Xiao Q, Zhang L. Reactive oxygen species: key regulators in vascular health and diseases. Br J Pharmacol. 2017;175:1279\u201392.","DOI":"10.1111\/bph.13828"},{"key":"4441_CR38","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1399-0004.2010.01619.x","volume":"80","author":"DA Stevenson","year":"2011","unstructured":"Stevenson DA, Schwarz EL, Carey JC, Viskochil DH, Hanson H, Bauer S, et al. Bone resorption in syndromes of the Ras\/MAPK pathway. Clin Genet. 2011;80:566\u201373.","journal-title":"Clin Genet"},{"key":"4441_CR39","doi-asserted-by":"crossref","first-page":"e12764","DOI":"10.1111\/acel.12764","volume":"17","author":"SY Zhu","year":"2018","unstructured":"Zhu SY, Zhuang JS, Wu Q, Liu ZY, Liao CR, Luo SG, et al. Advanced oxidation protein products induce pre-osteoblast apoptosis through a nicotinamide adenine dinucleotide phosphate oxidase-dependent, mitogen-activated protein kinases-mediated intrinsic apoptosis pathway. Aging Cell. 2018;17:e12764.","journal-title":"Aging Cell"},{"key":"4441_CR40","doi-asserted-by":"crossref","first-page":"101306","DOI":"10.1016\/j.redox.2019.101306","volume":"28","author":"CR Liao","year":"2020","unstructured":"Liao CR, Wang SN, Zhu SY, Wang YQ, Li ZZ, Liu ZY, et al. Advanced oxidation protein products increase TNF-alpha and IL-1beta expression in chondrocytes via NADPH oxidase 4 and accelerate cartilage degeneration in osteoarthritis progression. Redox Biol. 2020;28:101306.","journal-title":"Redox Biol"},{"key":"4441_CR41","doi-asserted-by":"crossref","first-page":"27285","DOI":"10.1074\/jbc.M702810200","volume":"282","author":"M Almeida","year":"2007","unstructured":"Almeida M, Han L, Martin-Millan M, Plotkin LI, Stewart SA, Roberson PK, et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem. 2007;282:27285\u201397.","journal-title":"J Biol Chem"},{"key":"4441_CR42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.job.2019.01.001","volume":"61","author":"W Feng","year":"2019","unstructured":"Feng W, Guo J, Li M. RANKL-independent modulation of osteoclastogenesis. J Oral Biosci. 2019;61:16\u201321.","journal-title":"J Oral Biosci"},{"key":"4441_CR43","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","volume":"13","author":"WC Dougall","year":"1999","unstructured":"Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 1999;13:2412\u201324.","journal-title":"Genes Dev"},{"key":"4441_CR44","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","volume":"97","author":"J Li","year":"2000","unstructured":"Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA. 2000;97:1566\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4441_CR45","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.kint.2018.10.032","volume":"95","author":"L Zhou","year":"2019","unstructured":"Zhou L, Chen X, Lu M, Wu Q, Yuan Q, Hu C, et al. Wnt\/beta-catenin links oxidative stress to podocyte injury and proteinuria. Kidney Int. 2019;95:830\u201345.","journal-title":"Kidney Int"},{"key":"4441_CR46","first-page":"166","volume":"28","author":"A Piwowar","year":"2010","unstructured":"Piwowar A. Advanced oxidation protein products. Part I. Mechanism of the formation, characteristics and property. Pol Merkur Lekarski. 2010;28:166\u20139.","journal-title":"Pol Merkur Lekarski"},{"key":"4441_CR47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.freeradbiomed.2018.08.036","volume":"132","author":"K Schr\u00f6der","year":"2019","unstructured":"Schr\u00f6der K. NADPH oxidases in bone homeostasis and osteoporosis. Free Radic Bio Med 2019;132:67\u201372.","journal-title":"Free Radic Bio Med"},{"key":"4441_CR48","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.7150\/thno.35414","volume":"9","author":"Y Liu","year":"2019","unstructured":"Liu Y, Wang C, Wang G, Sun Y, Deng Z, Chen L, et al. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities. Theranostics 2019;9:4648\u201362.","journal-title":"Theranostics"},{"key":"4441_CR49","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1172\/JCI67603","volume":"123","author":"C Goettsch","year":"2013","unstructured":"Goettsch C, Babelova A, Trummer O, Erben RG, Rauner M, Rammelt S, et al. NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis. J Clin Invest. 2013;123:4731\u20138.","journal-title":"J Clin Invest"},{"key":"4441_CR50","volume":"5","author":"F Xie","year":"2014","unstructured":"Xie F, Sun S, Xu A, Zheng S, Xue M, Wu P, et al. Advanced oxidation protein products induce intestine epithelial cell death through a redox-dependent, c-jun N-terminal kinase and poly (ADP-ribose) polymerase-1-mediated pathway. Cell Death Dis. 2014;5:e1006.","journal-title":"Cell Death Dis"},{"key":"4441_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2016.09.004","volume":"10","author":"R Ding","year":"2016","unstructured":"Ding R, Jiang H, Sun B, Wu X, Li W, Zhu S, et al. Advanced oxidation protein products sensitized the transient receptor potential vanilloid 1 via NADPH oxidase 1 and 4 to cause mechanical hyperalgesia. Redox Biol. 2016;10:1\u201311.","journal-title":"Redox Biol"},{"key":"4441_CR52","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.3390\/ijms19103004","volume":"19","author":"K Lee","year":"2018","unstructured":"Lee K, Seo I, Choi M, Jeong D. Roles of mitogen-activated protein kinases in osteoclast biology. Int J Mol Sci. 2018;19:3004.","journal-title":"Int J Mol Sci"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04441-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04441-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04441-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:52:04Z","timestamp":1669974724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04441-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,14]]},"references-count":52,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["4441"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-04441-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,14]]},"assertion":[{"value":"13 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1160"}}